Phenotypic variability of CMT4C in a French-Canadian kindred

Muscle and Nerve

Volumn 52, Issue 3, 2015, Pages 444-449

  Varley, Talia L ^a   Bourque, Pierre R ^b   Baker, Steven K ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

5q32; Charcot Marie Tooth; CMT4C; French Canadian; SH3TC2

Indexed keywords

ADULT; ARTICLE; CANADIAN; CHARCOT MARIE TOOTH TYPE 4C; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DNA SEQUENCE; FEMALE; FOOT MALFORMATION; FRENCHMAN; GENE; HAND GRIP; HEREDITARY MOTOR SENSORY NEUROPATHY; HETEROZYGOSITY; HUMAN; MALE; MOTOR UNIT POTENTIAL; MUSCLE ACTION POTENTIAL; MUSCLE ATROPHY; NERVE POTENTIAL; NONSENSE MUTATION; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; SH3TC2 GENE; VIBRATION SENSE; ACTION POTENTIAL; ELECTROMYOGRAPHY; GENETICS; NERVE CONDUCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; SIBLING;

PROTEIN; SH3TC2 PROTEIN, HUMAN;

ACTION POTENTIALS; ADULT; CHARCOT-MARIE-TOOTH DISEASE; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; NEURAL CONDUCTION; PHENOTYPE; PROTEINS; SIBLINGS;

EID: 84938969284     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.24640     Document Type: Article

References (18)

1. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet 1974;6:98-118.
2. Gabreëls-Festen A, van Beersum S, Eshuis L, LeGuern E, Gabreëls F, van Engelen B, et al. Study on the gene and phenotypic characterization of autosomal recessive demyelinating motor and sensory neuropathy (Charcot-Marie-Tooth disease) with a gene locus on chromosome 5q23-q33. J Neurol Neurosurg Psychiatry 1999;66:569-574.
3. Yger, M, Stojkovic, T, Tardieu S, Maisonobe T, Brice A, Echaniz-Laguna A, et al. Characteristics of clinical and electrophysiological pattern of Charcot-Marie-Tooth 4C. J Peripher Nerv Syst 2012;17:112-122. doi: 10.1111/j.1529-8027.2012.00382.x
4. The Mutation Database of Inherited Peripheral Neuropathies http://www.Molgen.ua.ac.be/CMTMutations/ Last accessed November 20, 2012.
5. Gosselin I, Thiffault I, Tétreault M, Chau V, Dicaire MJ, Loisel L, et al. Founder SH3TC2 mutations are responsible for a CMT4C French-Canadians cluster. Neuromuscul Disord 2008;18:483-492.
6. Kessali M, Zemmouri R, Guilbot A, Maisonobe T, Brice A, LeGuern E, et al. A clinical, electrophysiologic, neuropathologic, and genetic study of two large Algerian families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease. Neurology 1997;48:867-873.
7. Gooding R, Colomer J, King R, Angelicheva D, Marns L, Parman Y, et al. A novel Gypsy founder mutation, p.Arg1109X in the CMT4C gene, causes variable peripheral neuropathy phenotypes. J Med Genet 2005;42:e69.
8. Claramunt R, Sevilla T, Lupo V, Cuesta A, Millan JM, Vilchez JJ, et al. The p.R1109X mutation in SH3TC2 gene is predominant in Spanish Gypsies with Charcot-Marie-Tooth disease type 4. Clin Genet 2007;71:343-349.
9. LeGuern E, Guilbot A, Kessali M, Ravise N, Tassin J, Maisonobe T, et al. Homozygosity mapping of an autosomal recessive form of demyelinating Charcot-Marie-Tooth disease to chromosome 5q23-q33. Hum Mol Genet 2006;5:1685-1688.
10. Senderek J, Bergmann C, Stendel C, Kirfel J, Verpoorten N, De Jonghe P, et al. Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy. Am J Hum Genet 2003;73:1106-1119.
11. Guilbot A, Kessali M, Ravise N, Hammadouche T, Bouhouche A, Maisonobe T, et al. The autosomal recessive form of CMT disease linked to 5q31-q33. Ann N Y Acad Sci 1999;883:453-456.
12. Azzedine H, Ravise, N, Verny C, Gabrëels-Festen A, Lammens M, Grid D, et al. Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations. Neurology 2006;67:602-606.
13. Colomer J, Gooding R, Angelicheva D, King RH, Guillen-Navarro E, Parman Y, et al. Clinical spectrum of CMT4C disease in patients homozygous for the p.Arg1109X mutation in SH3TC2. Neuromuscul Disord 2006;16:449-453.
14. Medical Research Council MR. Aid to the examination of the peripheral nervous system. London: Her Majesty's Stationary Office; 1976.
15. Dalakas MC, Sonies B, Dambrosia J, Sekul E, Cupler E, Sivakumar K. Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study. Neurology 1997;48:712-716.
16. Houlden H, Laura M, Ginsberg L, Jungbluth H, Robb SA, Blake J, et al. The phenotype of Charcot-Marie-Tooth disease type 4C due to SH3TC2 mutations and possible predisposition to an inflammatory neuropathy. Neuromusc Disord 2009;19:264-269.
17. Horacek O, Mazanec R, Morris CE, Kobesova A. Spinal deformities in hereditary motor and sensory neuropathy: a retrospective qualitative, quantitative, genotypical, and familial analysis of 175 patients. Spine 2007;32:2502-2508.
18. Roberts RC, Peden AA, Buss F, Bright NA, Latoube M, Reilly M, et al. Mistargeting of SH3TC2 away from the recycling endosome causes Charcot-Marie-Tooth disease type 4C. Hum Mol Genet 2010;19:1009-1018.